Elaine K. Sorg - 18 Feb 2026 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role: Director
Signature: /s/ Andrew Cronauer, Attorney-in-Fact
Issuer symbol: ARTV
Transactions as of: 18 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 21:50:03 UTC
Previous filing: 27 Apr 2023
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sorg Elaine K.	Director	C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO	/s/ Andrew Cronauer, Attorney-in-Fact	19 Feb 2026	0001832571

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTV	Director Stock Option (Right to Buy)	Award	$0	+27,500		$0.000000	27,500	18 Feb 2026	Common Stock	27,500	$4.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following February 18, 2026.